Prescription medication · Androgen Hormone

testosterone

Also sold as AndroGel, Testim. Testosterone pellets treat low testosterone in men.

Data updated 2026-05-15

40,954
FDA reportsOften reported
2
InteractionsFew interactions
71% less
Generic vs brandBig savings
In shortage
FDA status

What the data shows

testosterone (AndroGel) is a prescription Androgen Hormone, reported at a middle-of-the-pack volume (40,954 FDA reports), whose generic runs roughly half the brand price or less (71% less).

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

testosterone (AndroGel) is a prescription Androgen Hormone. Testosterone pellets treat low testosterone in men.

Testosterone pellets (Testopel) are a hormone replacement therapy. They help men who don't produce enough testosterone on their own.

Drug Shortage Alert

testosterone is currently listed as to be discontinued by the FDA. Affected manufacturer: Actavis Pharma, Inc..

View all drug shortages →

Drug Pricing (NADAC)

Brand Price

$3.79/unit

Generic Price

$1.10/unit

Generic Savings

71%

Generic Available

Yes (30 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: TESTOSTERONE 1% (25 MG/2.5 G) PK

Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +7.3% vs prior release.

Effective NADAC / unit vs prior NDCs
April 17, 2024 $1.02/GM - 1
December 18, 2024 $1.10/GM +7.3% 2
Compare with Another Drug → Full Side Effects Report →

What it does

Testosterone pellets treat low testosterone in men.

Common side effects

Acne, Male-pattern baldness, Increased or decreased sex drive

Key warnings

Testosterone pellets can cause blood clots in your veins.

The sections below are summarized in plain English from testosterone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Testosterone is a male sex hormone. These pellets are implanted under the skin and slowly release testosterone into your body. This helps to restore normal testosterone levels.

Side Effects (from patient reports)

Based on 40,954 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for testosterone, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for testosterone each year to the FDA Adverse Event Reporting System (FAERS).

02,0004,0006,0008,000 20042007201020132016201920222025 1,783

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where testosterone sits

testosterone has more FDA adverse-event reports than 70% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is testosterone; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 40,954 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

40,954

Reports Mentioning Death

1,852

4.5% of reports — not proof of cause

Hospitalization Reports

9,033

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 3,659 (10%)
Male 34,487 (90%)

Age Distribution

0–17 555
18–44 3,952
45–64 10,318
65–74 3,762
75+ 1,584

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 MYOCARDIAL INFARCTION 3,269
3 PAIN 2,379
4 DEEP VEIN THROMBOSIS 2,176
5 BLOOD TESTOSTERONE DECREASED 2,093
6 CEREBROVASCULAR ACCIDENT 2,091
7 PULMONARY EMBOLISM 2,028
8 FATIGUE 2,004
9 ANXIETY 1,647
11 ASTHENIA 1,440
12 ECONOMIC PROBLEM 1,209
13 HEADACHE 1,182
14 NAUSEA 1,178
15 EMOTIONAL DISTRESS 1,034
16 INJURY 1,023
17 THROMBOSIS 976

Reactions in Death Reports

DEATH 617
MYOCARDIAL INFARCTION 366
CARDIAC ARREST 139
PULMONARY EMBOLISM 138
PAIN 127
CEREBROVASCULAR ACCIDENT 115
INJURY 80
DEEP VEIN THROMBOSIS 76
ANXIETY 75
PNEUMONIA 74

Reactions in Hospitalization Reports

MYOCARDIAL INFARCTION 1,149
PAIN 1,011
PULMONARY EMBOLISM 1,002
DEEP VEIN THROMBOSIS 922
CEREBROVASCULAR ACCIDENT 899
ANXIETY 716
ECONOMIC PROBLEM 530
ACUTE MYOCARDIAL INFARCTION 495
THROMBOSIS 451
INJURY 414

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Testosterone pellets can cause blood clots in your veins. This includes clots in your legs (deep vein thrombosis) and lungs (pulmonary embolism). Tell your doctor right away if you have pain, swelling, warmth, or redness in your leg, or if you have trouble breathing or chest pain.

Known Drug Interactions

However, clinical studies have shown that lovastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve, and does not reduce basal plasma testosterone concentration. Another HMG-CoA reductase inhibitor has been shown to reduce the plasma testosterone response to HCG. In the same study, the mean testosterone response to HCG was slightly but not significantly reduced after treatment with lovastatin 40 mg daily for 16 weeks in 21 men.

Mechanism: Lovastatin does not significantly lower the amount of testosterone in your blood or stop your body from making it.

The following laboratory tests may be affected by progestins including medroxyprogesterone acetate injectable suspension: (a) Plasma and urinary steroid levels are decreased (e.g., progesterone, estradiol, pregnanediol, testosterone, cortisol).

Mechanism: Medroxyprogesterone can lower the amount of testosterone found in your blood and urine.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

What if I experience prolonged erections?
Tell your doctor if you have erections that happen too often or last too long.
Can this medicine cause liver problems?
Yes, this medicine can sometimes cause liver problems. Your doctor will monitor your liver function.
Will this medicine affect my fertility?
High doses of testosterone can lower your sperm count.
Can this medicine cause mood changes?
Yes, some people experience anxiety or depression while taking this medicine.
How often will I need to get the pellets implanted?
You will likely need to get the pellets implanted every 3 to 6 months.
Can this medicine cause my body to retain fluid?
Yes, this medicine can cause your body to retain fluid, including sodium, chloride, water, potassium, calcium and inorganic phosphates.
Can testosterone pellets be used for age-related low testosterone?
No, the safety and effectiveness of testosterone pellets for age-related low testosterone have not been established.
What should I do if the implantation site gets infected?
Contact your doctor immediately if you notice any signs of infection at the implantation site, such as redness, swelling, or pus.
Can this medication cause breast enlargement?
Yes, this medication can cause breast enlargement in men (gynecomastia).
Can this medication cause changes in my skin?
Yes, this medication can cause acne, oily skin, and increased hair growth.
What are the common side effects of testosterone?
The registry lists Acne, Male-pattern baldness, Increased or decreased sex drive, Headache, Anxiety among the most-reported FAERS reaction terms for testosterone. The compiled record contains 40,954 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does testosterone interact with other medications?
The registry has 2 documented interaction rows for testosterone. Notable source-record pairings include lovastatin, medroxyprogesterone. These rows are not a complete medication review.
What drug class is testosterone?
testosterone belongs to the Androgen Hormone drug class. It requires a prescription (Rx). Testosterone pellets treat low testosterone in men.
Is there a generic version of testosterone?
Yes, generic testosterone is available from 30 manufacturers. The generic costs $1.10 per unit compared to $3.79 for the brand version, saving approximately 71%. Pricing is based on NADAC (National Average Drug Acquisition Cost) data from CMS.
What pregnancy or breastfeeding source fields are listed for testosterone?
The FDA label for testosterone contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has testosterone been recalled?
There are 28 recalls associated with testosterone products. Presence of Foreign substance - potential presence of metal particulate matter. Check the recalls section below for full details and affected products.
Is testosterone currently in shortage?
Yes, testosterone is currently listed as to be discontinued by the FDA. Affected manufacturer: Actavis Pharma, Inc.. Visit the FDA Drug Shortages database for the latest updates.

Active Recalls

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class II January 26, 2026

Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Class III November 7, 2025

Defective Container - A defect in the side-seal which allows leakage of product.

Teva Pharmaceuticals USA, Inc

Class II October 14, 2025

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

Class II October 14, 2025

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

Class II October 3, 2025

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

Advanced Pharmaceutical Technology, Inc.

Class III June 16, 2025

Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.

Qualgen, LLC

Class II April 28, 2025

Presence of Particulate Matter: Glass particles were found in pellet vials.

BSO LLC

Class II April 10, 2025

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Eugia US LLC

Class II August 8, 2024

Superpotent Drug

Teva Pharmaceuticals USA, Inc

Class II March 7, 2022

Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding

Class II March 7, 2022

Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding

Class II March 7, 2022

Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Class II May 29, 2013

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Other drugs grouped near testosterone - same-class peers and common alternatives.

Compare testosterone vs abiraterone side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for testosterone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on testosterone

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for testosterone

The FDA label for testosterone (sold under brand names such as AndroGel, Testim) classifies it as a prescription-only medication in the Androgen Hormone class. Testosterone pellets treat low testosterone in men. Official labeling lists 8 commonly reported side effects, including Acne, Male-pattern baldness, Increased or decreased sex drive.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 40,954 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $1.10 versus $3.79 for the brand - a 71% generic savings.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 28 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: July 17, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page